Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Parkinson: treat gait disorders by deep brain stimulation

Published on: 09/07/2015 Reading time: 1 min
Illustration 3D des noyaux subthalamique (NST, en rose) et pédonculopontin (NPP, en violet) ©Institut du Cerveau - ICM
Retour à la recherche

Gait and balance disorders and the associated falls caused by Parkinson disease are a major public health problem.

Institut du Cerveau - ICM researchers recently showed that the pedunculopontine nucleus, a region of the brainstem, is implicated in the control of gait in humans and that its stimulation could reduce the disorders that can occur in Parkinson disease.

In Parkinson disease, the motor symptoms are due to the progressive death of neurons in a region deep in the brain that uses dopamine as their chemical messenger. These symptoms generally disappear with L-dopa tretment or, in certain cases, deep brain stimulation of the subthalamic nucleus (NST),a region implicated in the control of movement.

However, in advanced forms of the disease, medical or surgical treatments are less effective, and the patient begins to suffer from gait disorders, "freezing*" and falls, which lead to wheelchair use after a certain period of evolution. Recent hypotheses indicate that these gait and balance problems are perhaps caused by the death of neurons in the pedunculopontine nucleus (NPP), a brain region implicated in the control of gait and balance.

In order to define the respective roles of the NST and NPP in the motor disorders, Institut du Cerveau - ICM researchers used a multidisciplinary experimental approach1 involving electrophysiological recordings during the neurosurgery to place electrodes for deep brain stimulation.

Fourteen patients with Parkinson disease were trained to perform a task in which they imagined themselves walking down a hallway. The patients, divided into two groups, then underwent surgery to place electrodes in the NST or NPP according to whether they had resistant gait disorders or not.

The results confirmed the preponderant role of the NPP in gait control even if, under normal conditions, the two nuclei probably interact to adapt movements to the environment.

In a second study,2 the neurologists and neurosurgeons of the Pitié-Salpêtrière Hospital followed six patients with electrodes for deep brain stimulation implanted in the NPP. This double-blind study showed a decrease in "freezing" and falls in three patients and improved posture control. The patients also described improvement in their quality of life. This encouraging result should be regarded with prudence, however, since risks related to the technique were observed during the study.

This study confirms that deep brain stimulation of the NPP could improve gait and balance disorders in some patients with Parkinson disease. However, the intervention involves risks and cannot be performed in all patients. These preliminary results reinforce our knowledge of this region of the human brainstem and open the way to the development of new treatments for this important public health problem.

*Sudden and brief immobilisation usually accompanied by festination with the feet stuck to the floor.

Sources

1. The integrative role of the pedunculopontine nucleus in human gait. Lau B, Welter ML, Belaid H, Fernandez Vidal S, Bardinet E, Grabli D, Karachi C.

2. PPNa-DBS for gait and balance disorders in Parkinson’s disease: a double-blind, randomised study. Welter ML, Demain A, Ewenczyk C, Czernecki V, Lau B, El Helou A, Belaid H, Yelnik J, François C, Bardinet E, Karachi C, Grabli D.

Our news on the subject

Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
See all our news